You are here » Home » Companies » Company Overview » Coral Laboratories Ltd

Coral Laboratories Ltd.

BSE: 524506 Sector: Health care
NSE: N.A. ISIN Code: INE683E01017
BSE LIVE 15:42 | 29 May 906.90 -189.10
(-17.25%)
OPEN

972.15

HIGH

1040.00

LOW

901.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 972.15
PREVIOUS CLOSE 1096.00
VOLUME 18873
52-Week high 1183.00
52-Week low 410.00
P/E 20.60
Mkt Cap.(Rs cr) 324
Buy Price 0.00
Buy Qty 0.00
Sell Price 906.90
Sell Qty 56.00
OPEN 972.15
CLOSE 1096.00
VOLUME 18873
52-Week high 1183.00
52-Week low 410.00
P/E 20.60
Mkt Cap.(Rs cr) 324
Buy Price 0.00
Buy Qty 0.00
Sell Price 906.90
Sell Qty 56.00

Coral Laboratories Ltd. (CORALLABS) - Company History

Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated. During the year 1999-2000, the company has received ISO-9002 Certification.